Our study aimed to characterize metformin as an adjunctive therapy in a population of young adults with T1D with different BMIs but similar ages, insulin doses (U/kg/day), glycemic control and time since diagnosis, in contrast to several studies in this way. The gene discussed is INS; the disease is type 1 diabetes mellitus.